Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (297)	5/19/1999 1:01:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 3559

>> Incapable management structure? Maybe, who knows? << Like you, I admire Schleifer. Like you, I appreciate the research foci and the capacity of REGN scientists for innovation. However, some CEOs got used to the idea that their job was to come to work every day and keep things on track. Things changed, and some CEOs were quick on their feet. Not many..... SUGN, GILD, LKST, etc. Schleifer got the money from PNG. Good job, but a bit conservative during crunch time.